The Pharma Letter

In Focus

Cuba a huge opportunity for life sciences, says Abivax

Cuba a huge opportunity for life sciences, says Abivax

Paris-based antiviral specialist Abivax has spoken in praise of the decision between the USA and Cuba on normalizing diplomatic relations.

Latest Pharmaceutical News

Latest Biotechnology News

Latest Generics News

Boardroom

Mergers & Acquisitions

Official: Merck & Co to acquire Cubist for $8.4 billion

Official: Merck & Co to acquire Cubist for $8.4 billion

Confirming weekend speculation and rumors, US pharma giant Merck & Co this morning said it has entered into a definitive agreement to acquire biotech firm Cubist Pharmaceuticals for $102 per share in cash.

Back to top